GlassScriptPhysician profile
Kalain Workman
NPI 1124470109
$11,618.61
in general payments reported to CMS, 2019-2025
13 companies · $259 in 2025
The $259 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.63 · 2020: $385 · 2021: $3,942 · 2022: $5,181 · 2023: $469 · 2024: $1,289 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,162 · Food and Beverage: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,162.40 |
| Food and Beverage | $854.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $7,789.75 | 2021-2025 | Real Intelligence, Collagenase Santyl |
| Zimmer Biomet Holdings, INC. | $1,885.91 | 2021-2025 | Rosa, Persona, Avenir |
| Omnilife Science, INC | $568.22 | 2022 | |
| Stryker Corporation | $520.61 | 2019-2025 | Mako, Restoration |
| Medical Device Business Services, INC. | $345.74 | 2020-2021 | |
| Depuy Synthes Sales INC. | $223.29 | 2019-2024 | Actis, Attune, Velys |
| Medtronic, INC. | $96.75 | 2022 | |
| Sanara Medtech INC. | $80.26 | 2020-2021 | |
| Microport Orthopedics INC | $34.10 | 2019 | |
| Heraeus Medical, LLC. | $23.73 | 2025 | |
| Ferring Pharmaceuticals INC. | $22.90 | 2025 | Euflexxa |
| Think Surgical, INC. | $19.04 | 2025 | |
| Nextstep Arthropedix, LLC | $8.31 | 2025 | Insitu Hip System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kalain Workman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.